The present disclosure pertains to medical devices, and methods for manufacturing medical devices. More particularly, the present disclosure pertains to medical devices including an attachable inner member and attachable outer member.
A wide variety of intracorporeal medical devices have been developed for medical use, for example, intravascular use. Some of these devices include heart valves, catheters, and the like. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.
This disclosure provides design, material, manufacturing method, and use alternatives for medical devices. An example system for delivering an implantable heart valve includes an inner shaft having a proximal end region, a distal end region and a first coupling member disposed along a portion of the distal end region, wherein the first coupling member includes a first aperture. The system also includes a support shaft having a proximal end region, a distal end region and a second coupling member disposed along a portion of the proximal end region, wherein the second coupling member includes a stem, wherein the stem includes a groove extending circumferentially around the stem. The system also includes a locking clip coupled to the inner shaft, wherein coupling the inner shaft to the support shaft includes extending at least a portion of the locking clip through the first aperture and into at least a portion of the groove.
Alternatively or additionally to any of the embodiments above, wherein the locking clip includes a first locking tab having an inner surface, a first end region and a second end region opposite the first end region, and wherein the first end region includes a first projection extending radially inward from the inner surface of the first locking tab.
Alternatively or additionally to any of the embodiments above, wherein the first projection is designed to extend through the first aperture and nest within the groove of the stem.
Alternatively or additionally to any of the embodiments above, wherein the first projection has a first engagement surface, the first engagement surface having radius of curvature, and wherein stem includes a second radius of curvature which substantially matches the first radius of curvature of the first engagement surface.
Alternatively or additionally to any of the embodiments above, wherein the locking clip includes a second locking tab having an inner surface, a first end region and a second end region opposite the first end region, and wherein the first end region includes a second projection extending radially inward from an inner surface of the second locking tab.
Alternatively or additionally to any of the embodiments above, wherein the first coupling member includes a second aperture, and wherein the second projection is designed to extend through the second aperture and nest within the groove of the stem.
Alternatively or additionally to any of the embodiments above, wherein the locking clip further includes a first connector and a second connector, and wherein each of the first connector and the second connector extends between the first locking tab and the second locking tab.
Alternatively or additionally to any of the embodiments above, wherein the first connector faces the second connector.
Alternatively or additionally to any of the embodiments above, wherein the first connector and the second connector are configured to bias the first locking tab toward the second locking tab.
Alternatively or additionally to any of the embodiments above, wherein the first projection and the second projection are configured to slide within the groove of the stem.
Alternatively or additionally to any of the embodiments above, wherein the first coupling member is configured to rotate relative to the second coupling member when the first projection and the second projection are positioned within the groove of the stem.
Another system for delivering an implantable heart valve includes a tip assembly having a distal end region and a proximal end region, a guidewire shaft coupled to the distal end region of the tip assembly and an inner shaft having a proximal end region, a distal end region and a first coupling member disposed along a portion of the distal end region, wherein the first coupling member includes a first aperture. The system also includes a support shaft having a proximal end region, a distal end region and a second coupling member disposed along a portion of the proximal end region, wherein the second coupling member includes a stem, wherein the stem includes a groove extending circumferentially around the stem. The system also includes a locking clip coupled to the inner shaft, wherein coupling the inner shaft to the support shaft includes extending at least a portion of the locking clip through the first aperture and into at least a portion of the groove.
Alternatively or additionally to any of the embodiments above, wherein the locking clip includes a first locking tab having an inner surface, a first end region and a second end region opposite the first end region, and wherein the first end region includes a first projection extending radially inward from the inner surface of the first locking tab.
Alternatively or additionally to any of the embodiments above, wherein the first projection is designed to extend through the first aperture and nest within the groove of the stem.
Alternatively or additionally to any of the embodiments above, wherein the locking clip includes a second locking tab having an inner surface, a first end region and a second end region opposite the first end region, and wherein the first end region includes a second projection extending radially inward from the inner surface of the second locking tab.
Alternatively or additionally to any of the embodiments above, wherein the first coupling member has a second aperture, and wherein the second projection is designed to extend through the second aperture and nest within the groove of the stem.
Alternatively or additionally to any of the embodiments above, wherein the locking clip further includes a first connector and a second connector, and wherein each of the first connector and the second connector extends between the first locking tab and the second locking tab.
Alternatively or additionally to any of the embodiments above, wherein the first connector and the second connector are configured to bias the first locking tab toward the second locking tab.
Alternatively or additionally to any of the embodiments above, wherein the first coupling member is configured to swivel relative to the second coupling member when the first projection and the second projection are positioned within the groove of the stem.
An example method for delivering an implantable heart valve includes attaching a first coupling member of an actuation shaft to a second coupling member of a support shaft using a locking clip of a medical device delivery system, the medical device delivery system including the implantable heart valve. Further, attaching the first coupling member of the actuation shaft to the second coupling member of the support shaft includes positioning a first projection of the locking clip through a first aperture of the first coupling member into a groove of the second coupling member. Additionally, the method also includes advancing the medical device delivery system to a target site adjacent the heart and deploying the implantable heart valve at the target site.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.
The disclosure may be more completely understood in consideration of the following detailed description in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about”, whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (e.g., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include one or more particular features, structures, and/or characteristics. However, such recitations do not necessarily mean that all embodiments include the particular features, structures, and/or characteristics. Additionally, when particular features, structures, and/or characteristics are described in connection with one embodiment, it should be understood that such features, structures, and/or characteristics may also be used connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
Diseases and/or medical conditions that impact the cardiovascular system are prevalent throughout the world. Traditionally, treatment of the cardiovascular system was often conducted by directly accessing the impacted part of the body. For example, treatment of a blockage in one or more of the coronary arteries was traditionally treated using coronary artery bypass surgery. As can be readily appreciated, such therapies are rather invasive to the patient and require significant recovery times and/or treatments. More recently, less invasive therapies have been developed. For example, therapies have been developed which allow a blocked coronary artery to be accessed and treated via a percutaneous catheter (e.g., angioplasty). Such therapies have gained wide acceptance among patients and clinicians.
Some relatively common medical conditions may include or be the result of inefficiency, ineffectiveness, or complete failure of one or more of the valves within the heart. For example, failure of the aortic valve or the mitral valve can have a serious effect on a human and could lead to serious health condition and/or death if not dealt with properly. Treatment of defective heart valves poses other challenges in that the treatment often requires the repair or outright replacement of the defective valve. Such therapies may be highly invasive to the patient. Disclosed herein are medical devices that may be used for delivering a medical device to a portion of the cardiovascular system in order to diagnose, treat, and/or repair the system. At least some of the medical devices disclosed herein may be used to deliver and implant a replacement heart valve (e.g., a replacement aortic valve, replacement mitral valve, etc.). In addition, the devices disclosed herein may deliver the replacement heart valve percutaneously and, thus, may be much less invasive to the patient. The devices disclosed herein may also provide a number of additional desirable features and benefits as described in more detail below.
The figures illustrate selected components and/or arrangements of a medical device system 10, shown schematically in
The medical device system 10 may generally be described as a catheter system that includes an outer shaft 12, an exoskeleton 14 extending at least partially through a lumen of the outer shaft 12, and a medical implant 16 (e.g., a replacement heart valve implant) which may be coupled to the exoskeleton 14 and disposed within a lumen of the outer shaft 12 during delivery of the medical implant 16. In some embodiments, a medical device handle 18 may be disposed at a proximal end of the outer shaft 12 and/or the exoskeleton 14 and may include one or more actuation mechanisms associated therewith. In other words, one or more tubular members (e.g., the outer shaft 12, the exoskeleton 14, etc.) may extend distally from the medical device handle 18. In general, the medical device handle 18 may be designed to manipulate the position of the outer shaft 12 relative to the exoskeleton 14 and/or facilitate the deployment of the medical implant 16.
In use, the medical device system 10 may be advanced percutaneously through the vasculature to a position adjacent to an area of interest and/or a treatment location. For example, in some embodiments, the medical device system 10 may be advanced through the vasculature to a position adjacent to a defective native valve (e.g., aortic valve, mitral valve, etc.). Alternative approaches to treat a defective aortic valve and/or other heart valve(s) are also contemplated with the medical device system 10. During delivery, the medical implant 16 may be generally disposed in an elongated and low profile “delivery” configuration within the lumen and/or a distal end of the outer shaft 12, as seen schematically in
It can be appreciated that during delivery and/or deployment of an implantable medical device (e.g., the medical implant 16), portions of the medical device system (e.g., the medical device system 10) may be required to be advanced through tortuous and/or narrow body lumens. Therefore, it may be desirable to utilize components and design medical delivery systems (e.g., such as the medical device system 10 and/or other medical devices) that reduce the profile of portions of the medical device while maintaining sufficient strength (compressive, torsional, etc.) and flexibility of the system as a whole.
In some instances, it may be desirable to design the medical device system 10 such that one or more device components may be disconnected from the medical device handle 18 when initially packaged (e.g., unattached to the exoskeleton 14, other inner shafts, etc.) whereby the one or more components may be subsequently coupled to the handle 18 after the packaging containing the medical device system 10 has been opened (and prior to a clinician utilizing the medical device system 10 in a medical procedure). For example, in some instances it may be desirable to package the medical implant 16 (e.g., heart valve, heart valve frame, the heart valve support structure, etc.) separately prior to performing the medical procedure. It can be appreciated that packaging the medical implant 16 (e.g., heart valve, heart valve frame, the heart valve support structure, etc.) separately may permit the medical implant 16 (including the heart valve, heart valve frame, the heart valve support structure, etc.) to be sterilized according to a different process, or kept at different temperatures, for example, than the remaining separately-packaged components of the medical device system 10.
As discussed above,
In some examples, the tubular guidewire member 36 may extend proximally within the lumen of an exoskeleton 14 and couple to the handle member 18 (it is noted that the exoskeleton 14 will be discussed in greater detail below). Additionally, the tubular guidewire member 36 may include a lumen which permits a guidewire to extend and translate therein. In other words, when fully assembled, the medical device system 10 may be advanced to a target site within a body over a guidewire extending within the lumen of the tubular guidewire member 36. Further, as discussed above, the tubular guidewire member 36 may extend from the handle member 18, through the lumen of the exoskeleton 14, through the implant medical and terminate at the tip assembly 24. Additionally, to attach the tubular guidewire member 36 to the tip assembly 24, the tubular guidewire member 36 may be advanced through the medical implant support structure 26 and the medical implant 16. Further, the tip assembly 24 and the tubular guidewire member 36 may be designed such that they “quick connect” (e.g., snap, attach, engage, etc.) together. Examples of attaching the tip assembly to a tubular guidewire member 36 are disclosed in U.S. Patent Application No. 62/887,088, the entirety of which is incorporated by reference.
As discussed above,
While
For example, as discussed above,
Further, in some examples, the exoskeleton 14 may include a plurality of discrete members or articulating links. For example, the exoskeleton 14 may include a plurality of bead members 41 and a plurality of barrel members 43. Other discrete members are contemplated that may have differing shapes and/or configurations. In general, the discrete members (e.g., the bead members 41 and the barrel members 43) are engaged with one another and are designed to increase the compression resistance, the tension resistance, or both of the exoskeleton 14 while also affording a desirable amount of flexibility and kink resistance such that the one or more inner shafts extending through the exoskeleton can be navigated through the anatomy. The bead members 41 and the barrel members 43 may be arranged in a number of different configurations. In at least some instances, the bead members 41 and the barrel members 43 alternate along the exoskeleton 14. Other arrangements and/or patterns are contemplated. Example exoskeletons are disclosed in U.S. Patent Publication No. US20180140323, the entirety of which is incorporated by reference.
Additionally,
Additionally, as will be described in greater detail below,
It is noted that
Additionally, as discussed above,
In some examples, an operator may be able to manipulate the translation members 22 via the handle 18 (which is coupled to the translation members 22 via the actuation shaft 17, first actuation coupling member 19 and second actuation coupling member 20). For example, the handle 18 may be designed to control the translation of the translation members 22. Further, actuation of the translation members 22 may help deploy the medical implant 16 at a target site adjacent the heart. Example translation members are disclosed in U.S. patent application Ser. No. 16/396,089, the entirety of which is incorporated by reference.
Additionally, as will be described in greater detail below,
In some instances, the order of connecting separately packaged components may include first advancing the guidewire shaft 36 through the medical implant. Next, the first actuation coupling member 19 may be attached to the second actuation coupling member 20. After this connection is made, the actuation shaft 17 may be retracted such that the first exoskeleton coupling member 30 may be attached to the implant support structure 26 via the second exoskeleton coupling member 28. Finally, the nosecone 24 may be attached to the distal end region of the guidewire shaft 36.
Additionally,
In some instances, the translation members 22 may be secured to the second actuation coupling member 20 via welding the securement collar 54 directly to the second actuation coupling member 20. Further, in some examples, the aperture 50 may be utilized during the welding process to assure that the securement collar 54 is properly aligned with the second actuation coupling member 20.
As discussed above,
As will be shown below with respect to
Additionally,
It can further be appreciated from
It can be further appreciated that the securement collar 54 may include a gap 69 which prevents the securement collar 54 from extending continuously around its longitudinal axis 70 (it is noted that the securement collar 54 shares the same longitudinal axis 70 as the locking clip 32 described above). Therefore, the securement collar 54 may be designed to flex such that it may flex around and onto (e.g., it may snap onto) the translation members 22 (collectively) whereby each of the flat surfaces 58 engage each of the notched regions 60, respectively.
Additionally,
It can be further appreciated that when the first locking projection 40a and the second locking projection 40b are positioned within the channel 46, the locking clip 32 is prevented from moving distally relative to the first actuation coupling member 19. In other words, when positioned within the channel 46, the first locking projection 40a and the second locking projection 40b may abut the wall defining the first aperture 40a and the second aperture 40b, respectively, and are thereby prevented from moving in a distal direction (e.g., a direction toward the second actuation coupling member 20).
Further, the engagement of the first locking projection 40a and the second locking projection 40b within the channel 46 (via extending through the first aperture 40a and the second aperture 40b, respectively) may prevent the second actuation coupling member 20 from being pulled away from the second actuation coupling member 20. As described above, the first curved portion 64a and the second curved portion 64b of the locking clip 32 may provide a radially-inward force which biases the first locking tab 38a and second locking tab 38b (and hence, the first locking projection 40a and the second locking projection 40b) toward the channel 46, thereby preventing the first locking tab 38a and second locking tab 38b (and hence, the first locking projection 40a and the second locking projection 40b) from flexing radially away from the channel 46. In other words, the first curved portion 64a and the second curved portion of the locking clip 32 provide a force toward the longitudinal axis of the first actuation locking member 19 which is designed to maintain the first locking projection 40a and the second locking projection 40b within the channel 46 and thereby prevent the stem 44 from being pulled out of the lumen 52 of the first actuation coupling member 19.
Additionally, it can be appreciated that when the first locking projection 40a and the second locking projection 40b are nested within the channel 46, the second actuation coupling member 20 may be permitted to swivel (e.g., spin along its longitudinal axis) relative to both the first locking actuation member 19 and the actuation shaft locking clip 32. Because the first locking projection 40a and the second locking projection 40b extend through the first aperture 40a and the second aperture 40b, respectively, the first actuation coupling member 20 and the locking clip 32 may rotate together around the stem 44 of the second actuation coupling member 20, while the first locking projection 40a and the second locking projection 40b remain engaged within the channel and slide within the channel 46.
Some example materials that can be used for the various components of the medical device system 10 are described herein. However, this is not intended to limit the devices and methods described herein, as the other materials may be utilized for the medical device system 10 and components thereof.
Additionally, medical device system 10 and components thereof may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, ceramics, combinations thereof, and the like, or other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), high density polyethylene (HDPE), polyester, Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), ultra-high molecular weight (UHMW) polyethylene, polypropylene, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the sheath can be blended with a liquid crystal polymer (LCP).
Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-NR and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; titanium; combinations thereof; and the like; or any other suitable material.
In at least some embodiments, portions or all of the medical device system 10 and components thereof may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of the shaft in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands and/or coils may also be incorporated into the design of the medical device system 10 and components thereof to achieve the same result.
In some embodiments, a degree of Magnetic Resonance Imaging (MRI) compatibility is imparted into the shaft. For example, the medical device system 10 and components thereof may include a material that does not substantially distort the image and create substantial artifacts (e.g., gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. The medical device system 10 and components thereof may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-NR and the like), nitinol, and the like, and others.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The disclosure's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims the benefit of priority of U.S. Provisional Application No. 63/141,777 filed Jan. 26, 2021, the entire disclosure of which is hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
3674014 | Tillander | Jul 1972 | A |
4798598 | Bonello et al. | Jan 1989 | A |
4955384 | Taylor et al. | Sep 1990 | A |
4985022 | Fearnot et al. | Jan 1991 | A |
4998923 | Samson et al. | Mar 1991 | A |
5003989 | Taylor et al. | Apr 1991 | A |
5035706 | Giantureo et al. | Jul 1991 | A |
5095915 | Engelson | Mar 1992 | A |
5315996 | Lundquist | May 1994 | A |
5406960 | Corso, Jr. | Apr 1995 | A |
5437288 | Schwartz et al. | Aug 1995 | A |
5570701 | Ellis et al. | Nov 1996 | A |
5599492 | Engelson | Feb 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5746701 | Noone | May 1998 | A |
5749837 | Palermo et al. | May 1998 | A |
5769796 | Palermo et al. | Jun 1998 | A |
5772609 | Nguyen et al. | Jun 1998 | A |
5776080 | Thome et al. | Jul 1998 | A |
5800456 | Maeda et al. | Sep 1998 | A |
5833632 | Jacobsen et al. | Nov 1998 | A |
5902254 | Magram | May 1999 | A |
5931830 | Jacobsen et al. | Aug 1999 | A |
5951494 | Wang et al. | Sep 1999 | A |
6001068 | Uchino et al. | Dec 1999 | A |
6017319 | Jacobsen et al. | Jan 2000 | A |
6139510 | Palermo | Oct 2000 | A |
6221096 | Aiba et al. | Apr 2001 | B1 |
6254628 | Wallace et al. | Jul 2001 | B1 |
6273876 | Klima et al. | Aug 2001 | B1 |
6398776 | Sekino et al. | Jun 2002 | B1 |
6565597 | Fearnot et al. | May 2003 | B1 |
6606921 | Noetzold | Aug 2003 | B2 |
6739787 | Bystrom | May 2004 | B1 |
6764503 | Ishimaru | Jul 2004 | B1 |
6918882 | Skujins et al. | Jul 2005 | B2 |
6921397 | Corcoran et al. | Jul 2005 | B2 |
7055656 | Drew | Jun 2006 | B2 |
7074197 | Reynolds et al. | Jul 2006 | B2 |
7338495 | Adams | Mar 2008 | B2 |
7413563 | Corcoran et al. | Aug 2008 | B2 |
7533906 | Luettgen et al. | May 2009 | B2 |
7540865 | Griffin et al. | Jun 2009 | B2 |
7579550 | Dayton et al. | Aug 2009 | B2 |
7618379 | Reynolds et al. | Nov 2009 | B2 |
7625364 | Corcoran et al. | Dec 2009 | B2 |
7780611 | Griego et al. | Aug 2010 | B2 |
7784376 | Wen | Aug 2010 | B2 |
7824345 | Euteneuer et al. | Nov 2010 | B2 |
7841994 | Skujins et al. | Nov 2010 | B2 |
7850623 | Griffin et al. | Dec 2010 | B2 |
7854109 | Zubiate et al. | Dec 2010 | B2 |
7914466 | Davis et al. | Mar 2011 | B2 |
7914467 | Layman et al. | Mar 2011 | B2 |
7918080 | Zubiate et al. | Apr 2011 | B2 |
7993286 | Reynolds et al. | Aug 2011 | B2 |
8022331 | Reynolds et al. | Sep 2011 | B2 |
8047236 | Perry | Nov 2011 | B2 |
8048004 | Davis et al. | Nov 2011 | B2 |
8048060 | Griffin et al. | Nov 2011 | B2 |
8080053 | Satasiya et al. | Dec 2011 | B2 |
8099939 | Zubiate et al. | Jan 2012 | B2 |
8100031 | Zubiate et al. | Jan 2012 | B2 |
8105246 | Voeller et al. | Jan 2012 | B2 |
8124876 | Dayton et al. | Feb 2012 | B2 |
8137293 | Zhou et al. | Mar 2012 | B2 |
8147534 | Berez et al. | Apr 2012 | B2 |
8157751 | Adams et al. | Apr 2012 | B2 |
8182465 | Griffin et al. | May 2012 | B2 |
8192422 | Zubiate et al. | Jun 2012 | B2 |
8197419 | Field et al. | Jun 2012 | B2 |
8231551 | Griffin et al. | Jul 2012 | B2 |
8328868 | Paul et al. | Jul 2012 | B2 |
8257279 | Davis et al. | Sep 2012 | B2 |
8292829 | Griego et al. | Oct 2012 | B2 |
8317777 | Zubiate et al. | Nov 2012 | B2 |
8376865 | Forster et al. | Feb 2013 | B2 |
8376961 | Layman et al. | Feb 2013 | B2 |
8377035 | Zhou et al. | Feb 2013 | B2 |
8397481 | Zubiate et al. | Mar 2013 | B2 |
8409114 | Parins | Apr 2013 | B2 |
8414506 | Reynolds et al. | Apr 2013 | B2 |
8425408 | Boulais et al. | Apr 2013 | B2 |
8443692 | Zubiate et al. | May 2013 | B2 |
8449526 | Snyder et al. | May 2013 | B2 |
8459138 | Zubiate et al. | Jun 2013 | B2 |
8475366 | Boulais et al. | Jul 2013 | B2 |
8485992 | Griffin et al. | Jul 2013 | B2 |
8535219 | Smith et al. | Sep 2013 | B2 |
8535243 | Shireman | Sep 2013 | B2 |
8551020 | Chen et al. | Oct 2013 | B2 |
8551021 | Voeller et al. | Oct 2013 | B2 |
8556914 | Vrba | Oct 2013 | B2 |
8608648 | Banik et al. | Dec 2013 | B2 |
8622894 | Banik et al. | Jan 2014 | B2 |
8636716 | Griffin et al. | Jan 2014 | B2 |
8656697 | Zubiate et al. | Feb 2014 | B2 |
8677602 | Dayton et al. | Mar 2014 | B2 |
8758268 | Bown et al. | Jun 2014 | B2 |
8784337 | Voeller et al. | Jul 2014 | B2 |
8795202 | Northrop et al. | Aug 2014 | B2 |
8795254 | Layman et al. | Aug 2014 | B2 |
8821477 | Northrop et al. | Sep 2014 | B2 |
8833197 | Zubiate et al. | Sep 2014 | B2 |
8845552 | Griego et al. | Sep 2014 | B2 |
8864654 | Kleiner et al. | Oct 2014 | B2 |
8870790 | Davis et al. | Oct 2014 | B2 |
8900163 | Jacobsen et al. | Dec 2014 | B2 |
8915865 | Jacobsen et al. | Dec 2014 | B2 |
8932235 | Jacobsen et al. | Jan 2015 | B2 |
8936558 | Jacobsen et al. | Jan 2015 | B2 |
8939916 | Jacobsen et al. | Jan 2015 | B2 |
8945096 | Zubiate et al. | Feb 2015 | B2 |
9005114 | Zubiate et al. | Apr 2015 | B2 |
9011318 | Choset et al. | Apr 2015 | B2 |
9023011 | Griffin et al. | May 2015 | B2 |
9072874 | Northrop et al. | Jul 2015 | B2 |
9370432 | Bennett et al. | Jun 2016 | B2 |
9375234 | Vrba | Jun 2016 | B2 |
9386911 | Zubiate et al. | Jul 2016 | B2 |
9387308 | Hinchliffe et al. | Jul 2016 | B2 |
9387309 | Parodi et al. | Jul 2016 | B2 |
9402682 | Worrell et al. | Aug 2016 | B2 |
9993360 | Shalev et al. | Jun 2018 | B2 |
10092426 | McHugo | Oct 2018 | B2 |
10258465 | Salahieh et al. | Apr 2019 | B2 |
10646365 | Berra et al. | May 2020 | B2 |
11266518 | Poppe et al. | Mar 2022 | B2 |
20010037141 | Yee et al. | Nov 2001 | A1 |
20030069520 | Skujins et al. | Apr 2003 | A1 |
20030069521 | Reynolds et al. | Apr 2003 | A1 |
20040064179 | Linder et al. | Apr 2004 | A1 |
20040193244 | Hartley et al. | Sep 2004 | A1 |
20040220499 | Griego et al. | Nov 2004 | A1 |
20040243143 | Corcoran et al. | Dec 2004 | A1 |
20050080400 | Corcoran et al. | Apr 2005 | A1 |
20050090848 | Adams | Apr 2005 | A1 |
20050267444 | Griffin et al. | Dec 2005 | A1 |
20060111615 | Danitz et al. | May 2006 | A1 |
20060122537 | Reynolds et al. | Jun 2006 | A1 |
20060179966 | Kuo | Aug 2006 | A1 |
20060189896 | Davis et al. | Aug 2006 | A1 |
20070049902 | Griffin et al. | Mar 2007 | A1 |
20070066900 | O'Keeffe | Mar 2007 | A1 |
20070083132 | Sharrow | Apr 2007 | A1 |
20070100285 | Griffin et al. | May 2007 | A1 |
20070114211 | Reynolds et al. | May 2007 | A1 |
20070135734 | Reynolds et al. | Jun 2007 | A1 |
20070233043 | Dayton et al. | Oct 2007 | A1 |
20070244414 | Reynolds et al. | Oct 2007 | A1 |
20070265637 | Andreas et al. | Nov 2007 | A1 |
20080009829 | Ta et al. | Jan 2008 | A1 |
20080064989 | Chen et al. | Mar 2008 | A1 |
20080077119 | Snyder et al. | Mar 2008 | A1 |
20080194994 | Bown et al. | Aug 2008 | A1 |
20080205980 | Zubiate et al. | Aug 2008 | A1 |
20080245173 | Schwerin et al. | Oct 2008 | A1 |
20080255655 | Kusleika et al. | Oct 2008 | A1 |
20080262474 | Northrop | Oct 2008 | A1 |
20090036833 | Parins | Feb 2009 | A1 |
20090043228 | Northrop et al. | Feb 2009 | A1 |
20090043283 | Turnlund et al. | Feb 2009 | A1 |
20090143768 | Parodi et al. | Jun 2009 | A1 |
20090156999 | Adams et al. | Jun 2009 | A1 |
20090171151 | Choset et al. | Jul 2009 | A1 |
20090312606 | Dayton et al. | Dec 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20100063480 | Shireman | Mar 2010 | A1 |
20100076266 | Boulais et al. | Mar 2010 | A1 |
20100080892 | O'Brien et al. | Apr 2010 | A1 |
20100145308 | Layman et al. | Jun 2010 | A1 |
20100234933 | Punga et al. | Sep 2010 | A1 |
20100249655 | Lemon | Sep 2010 | A1 |
20100274187 | Argentine | Oct 2010 | A1 |
20100286566 | Griffin et al. | Nov 2010 | A1 |
20100294071 | Zubiate et al. | Nov 2010 | A1 |
20100305475 | Hinchliffe et al. | Dec 2010 | A1 |
20110056320 | Zubiate et al. | Mar 2011 | A1 |
20110082443 | Griffin et al. | Apr 2011 | A1 |
20110152613 | Zubiate et al. | Jun 2011 | A1 |
20110178588 | Haselby | Jul 2011 | A1 |
20110184241 | Zubiate et al. | Jul 2011 | A1 |
20110218620 | Meiri et al. | Sep 2011 | A1 |
20110257478 | Kleiner et al. | Oct 2011 | A1 |
20110264191 | Rothstein | Oct 2011 | A1 |
20120041411 | Horton et al. | Feb 2012 | A1 |
20120160537 | Wen | Jun 2012 | A1 |
20120265134 | Echarri et al. | Oct 2012 | A1 |
20130085562 | Rincon et al. | Apr 2013 | A1 |
20130123796 | Sutton et al. | May 2013 | A1 |
20130123912 | Tung | May 2013 | A1 |
20130131775 | Hadley et al. | May 2013 | A1 |
20130144276 | Crisostomo et al. | Jun 2013 | A1 |
20140235361 | Forster et al. | Aug 2014 | A1 |
20150250481 | Chobotov | Sep 2015 | A1 |
20160100941 | Czyscon et al. | Apr 2016 | A1 |
20160184117 | Vad et al. | Jun 2016 | A1 |
20160256304 | Roeder et al. | Sep 2016 | A1 |
20160302921 | Gosal et al. | Oct 2016 | A1 |
20160317301 | Quadri et al. | Nov 2016 | A1 |
20180140323 | Foster | May 2018 | A1 |
20180263771 | Poppe | Sep 2018 | A1 |
20180263773 | Poppe | Sep 2018 | A1 |
20190038408 | Calomeni | Feb 2019 | A1 |
20190070001 | Calomeni | Mar 2019 | A1 |
20190328523 | Poppe | Oct 2019 | A1 |
Number | Date | Country |
---|---|---|
0778040 | Jun 1997 | EP |
1168986 | Jan 2002 | EP |
2455128 | May 2013 | EP |
2001522694 | Nov 2000 | JP |
2001504016 | Mar 2001 | JP |
2010088545 | Apr 2010 | JP |
2011087947 | May 2011 | JP |
2012501725 | Jan 2012 | JP |
2012223578 | Nov 2012 | JP |
2013517910 | May 2013 | JP |
2013524943 | Jun 2013 | JP |
2014508568 | Apr 2014 | JP |
2014513585 | Jun 2014 | JP |
5575840 | Aug 2014 | JP |
2015500063 | Jan 2015 | JP |
2015501680 | Jan 2015 | JP |
2016067915 | May 2016 | JP |
2017507744 | Mar 2017 | JP |
9820811 | May 1998 | WO |
9925280 | May 1999 | WO |
2006041612 | Apr 2006 | WO |
2006073581 | Jul 2006 | WO |
2010027485 | Mar 2010 | WO |
2011094527 | Aug 2011 | WO |
2011133486 | Oct 2011 | WO |
20120966687 | Jul 2012 | WO |
2012116368 | Aug 2012 | WO |
2016196933 | Dec 2016 | WO |
2018170092 | Sep 2018 | WO |
2018204558 | Nov 2018 | WO |
Entry |
---|
International Search Report and Written Opinion dated Mar. 2, 2018 for International Application No. PCT/US2017/062113. |
International Search Report and Written Opinion dated May 25, 2018 for International Application No. PCT/US2018/022371. |
International Search Report and Written Opinion dated Jun. 15, 2018 for International Application No. PCT/US2018/022377. |
International Search Report and Written Opinion dated Aug. 31, 2018 for International Application No. PCT/US2018/030751. |
International Search Report and Written Opinion dated Jun. 27, 2019 for International Application No. PCT/US2019/029336. |
International Search Report and Written Opinion dated Aug. 16, 2019 for International Application No. PCT/US2019/029345. |
Notice of Reasons for Refusal dated Dec. 14, 2021 for Japanese Patent Application No. 2020-0559546. |
Number | Date | Country | |
---|---|---|---|
20220233313 A1 | Jul 2022 | US |
Number | Date | Country | |
---|---|---|---|
63141777 | Jan 2021 | US |